Telix to Acquire ITM Isotope Technologies in $2.35 Billion Deal
The Australian company secures a major supplier of radioactive materials for cancer treatments and adds a late-stage drug candidate.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Telix Pharmaceuticals Ltd.
- ITM Isotope Technologies Munich SE